March 20 2020
Posted December 13, 2018
A recent opinion piece published in Nature argues for transparency and open discussion when evaluating the reasons behind drug failures in clinical trials for Alzheimer’s disease. The piece includes a link for recommended guidelines for clinical trial design as well as potential data-sharing initiatives. The goal of the editorial is to promote an open discussion of the learning opportunities that are hidden within each failure.
March 20 2020
December 19 2019
December 19 2019
December 19 2019
December 19 2019
December 19 2019